Jove
Visualize
Contact Us

Related Experiment Videos

HIV-associated hypogonadism.

Gary R Cohan1

  • 1Robertson Diagnostic Center, Beverly Hills, California, USA.

The AIDS Reader
|August 1, 2006
PubMed
Summary
This summary is machine-generated.

Men with HIV may experience early andropause due to hypogonadism. Testosterone replacement therapy should aim for stable, physiologic levels to manage this condition effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective study of topical testosterone gel (AndroGel) versus intramuscular testosterone in testosterone-deficient HIV-infected men.

HIV clinical trials·2007
Same journal

Effect of antiretroviral resistance on response in treatment-experienced patients.

The AIDS reader·2009
Same journal

Maximizing treatment outcome: key considerations for antiretroviral-experienced patients.

The AIDS reader·2009
Same journal

Utilizing a new class of antiretrovirals: role of fusion inhibitors in HIV disease management.

The AIDS reader·2009
Same journal

Economic crisis threatens AIDS fight.

The AIDS reader·2009
Same journal

Editorial comment: mixing tenofovir with other nephrotoxins--how safe is this?

The AIDS reader·2009
Same journal

Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.

The AIDS reader·2009
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Endocrinology
  • Infectious Diseases
  • Men's Health

Background:

  • Hypogonadism is a concern for men with HIV, even with controlled viral replication and normalized CD4+ counts.
  • Men with HIV may exhibit "early andropause" due to hypothalamic-pituitary axis dysregulation.
  • Testosterone levels, often bound to albumin and sex hormone-binding globulin, may require free testosterone testing for equivocal total levels.

Purpose of the Study:

  • To address the ongoing concern of hypogonadism in men with HIV.
  • To explore the potential for "early andropause" syndrome in this population.
  • To provide guidance on managing hypogonadism in men with HIV.

Main Methods:

  • Review of existing literature on hypogonadism in HIV.
  • Analysis of hormonal regulation in men with HIV.

Related Experiment Videos

  • Evaluation of testosterone testing and replacement strategies.

    • Main Results:

    • Hypogonadism is prevalent in men with HIV, irrespective of viral control.
    • Dysregulation of the hypothalamic-pituitary axis contributes to early andropause symptoms.
    • Free testosterone testing may be necessary for accurate diagnosis.
    • Physiologic testosterone replacement is preferred over supraphysiologic levels.

    Conclusions:

    • Hypogonadism and early andropause are significant concerns for men with HIV.
    • Accurate testosterone level assessment, including free testosterone, is crucial.
    • Testosterone replacement therapy should aim for stable, physiologic levels.